Solution
Industries
Resources
About
Beacon Search

DNA Sequencing: Emerging Technologies and Applications

Report Code: BIO045B

Publish Date: Aug 2008

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global DNA sequencing industry was worth $794.1 million in 2007. This is expected to reach $862.5 million in 2008 and $1.7 billion in 2013, a compound annual growth rate (CAGR) of 14.7%./li>
  • Research and drug discovery/development generated global revenues of $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and $1.0 billion in 2013, for a CAGR of 9.7%.
  • Commercial applications were valued at $193.6 million in 2007 and an estimated $218.8 million in 2008. This segment should reach $426.1 million in 2013, a CAGR of 14.3%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

BCC’s goal for this study is to determine the status of current and next generation DNA sequencing technologies and products and assess their worldwide growth potential over a five-year period from 2008 to 2013. Our particular interest is to characterize and quantify the DNA sequencing products market potential by application, technology, analysis type, geography and end user. Sequencing applications market segments that will provide substantial future growth opportunities for next generation DNA sequencing companies include research, drug discovery and development, forensics and human identification, bacterial genomics, agricultural genomics, clinical diagnostics and personal genomics. 
 
Our main objective is to present a comprehensive discussion of where the state-of-the-art is in DNA sequencing technologies, and assess the state of the sequencing industry and the current and future commercial potential for the key market segments. 
 
REASONS FOR DOING THE STUDY
 
The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome. A significant outcome of the HGP was improvements in the efficiency and costs of DNA sequencing. During this time period, the DNA sequencing industry consolidated, resulting in one dominant company: Applied Biosystems. In 2008, in the post-HGP era, new DNA sequencing technologies are emerging that will radically alter the structure of the industry and open up substantial new market applications. Contributing to the rise of these new sequencing technologies are advances in nanotechnology, microfluidics, imaging, enzymology, and bioinformatics. Based on these market and technology dynamics, it is timely to examine the future DNA sequencing markets. 
 
Ongoing discoveries in nanotechnology, bioinformatics, microfluidics, imaging, enzymology and bioinformatics are revolutionizing many life science fields, and providing novel platforms for next generation DNA sequencing. At the same time this is occurring, there is a growing market demand for analysis of the genomes of many species and cancers, and for understanding the role of genetic variation among individuals in disease. The genetic analysis industry seeks to meet these needs with tools such as microarrays, real time polymerase chain reaction (RT-PCR) and DNA sequencing instruments. With the novel next generation sequencing technologies, applications space vis-à-vis the other genetic analysis tools has widened, and this report seeks to understand this trend and its significance for companies supplying DNA sequencing products and services. 
 
The next generation DNA sequencing technologies will change the dynamics of the current DNA sequencing industry and create novel market opportunities. This report analyzes these trends and their impact on the future markets for DNA sequencing technologies.
 
It is particularly timely to gain an understanding of these industry and technology forces, and the impact on the genetic analysis markets.
 
INTENDED AUDIENCE
 
We have compiled a study of existing and next generation technologies that will be commercially important in the major end user segments of life science research, drug discovery and development, forensics and human identification, bacterial genomics, agricultural genomics, clinical diagnostics and personal genomics. We present both Sanger sequencing and next generation, non-Sanger sequencing technologies as well as market growth driving forces, product formats, market applications, companies and industry alliances, future market potential and product sales forecasts for the period 2008 through 2013. We forecast the use of sequencing products for these end user segments: major sequencing centers, academic genome centers, government labs, pharmaceutical/biotech labs, small to mid-size labs and sequencing service labs.
 
This study will be of particular interest to life science research tools suppliers, pharmaceutical manufacturers, diagnostics, nanotechnology, and biotechnology companies. It will also be valuable to companies involved in genome sequencing projects, sequencing centers, manufacturers of microarrays, suppliers of molecular diagnostics assays, bioinformatics companies, and cancer researchers and clinicians. 
 
SCOPE OF REPORT
 
The study scope includes DNA sequencing technologies likely to be commercialized within the next five years. Sanger and next generation (non-Sanger sequencing) technologies are included. Each technology is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2008 through 2013. Advantages and limitations of each technology together with market driving forces are discussed.
 
BCC examines the sequencing industry structure, strategic industry alliances and acquisitions, and sequencing patents.   The strategies of the main Sanger and next generation sequencing companies are discussed. The markets for sequencing applications, including de novo whole genome sequencing, re-sequencing, ChipSeq, MethylSeq and RNASeq, are analyzed. 
 
METHODOLOGY
 
BCC surveyed key users and producers in each of the market applications that will be commercially important during the next five years: research, drug discovery and development, forensics and human ID, bacterial genomics, agricultural genomics, clinical diagnostics and personal genomics.   Based on our industry discussions and market analysis, we project the future applications of sequencing platforms and forecast sales revenues for 2008 through 2013.
 
The sequencing market is analyzed by technology, product type, application, customer, analysis type, geography and genome type, with forecasts of market demand from 2008 through 2013. We analyze which applications and analyses will be important to the future of DNA sequencing, and the customer groups that will be consumers of the technologies. We also analyze the impact of other genetic analysis technologies like microarrays on the growth of sequencing.
 
INFORMATION SOURCES
 
BCC surveyed leading DNA sequencing, biotechnology, and nanotechnology companies as well as core sequencing facilities and laboratories to obtain data for this study. Included were research tools, drug, biotechnology and nanotechnology firms, and leading life science research institutions. We also spoke with leading industry thinkers. In addition, we compiled data from secondary sources including industry, trade, and government.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: DNA Sequencing: Emerging Technologies and Applications237Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW10Free
Chapter- 4: DNA SEQUENCING TECHNOLOGIES51Free
Chapter- 5: DNA SEQUENCING APPLICATIONS18Free
Chapter- 6: DNA SEQUENCING INITIATIVES21Free
Chapter- 7: DNA SEQUENCING INDUSTRY STRUCTURE27Free
Chapter- 8: DNA SEQUENCING MARKETS37Free
Chapter- 9: DNA SEQUENCING PATENT STATUS15Free
Chapter- 10: C. CRAMER & CO. GMBH51Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 56

  • Summary Table: GLOBAL VALUE OF DNA SEQUENCING, BY END USE APPLICATION, THROUGH 2013
  • Table 1: SCOPE OF THIS REPORT
  • Table 2: GLOBAL VALUE OF DNA SEQUENCING, BY END USE APPLICATION, THROUGH 2013
  • Table 3: DNA SEQUENCING KEY GROWTH DRIVING FORCES
  • Table 4: LIFE CYCLE STATUS OF NEXT GENERATION SEQUENCING PLATFORMS
  • Table 5: COMPANY POSITIONING BY SEQUENCING TECHNOLOGY
  • Table 6: SCOPE OF KEY GENETIC ANALYSIS TECHNOLOGIES
  • Table 7: GENETIC ANALYSIS HISTORY
  • Table 8: LIMITATIONS OF SANGER SEQUENCING TECHNOLOGY
  • Table 9: IMPROVEMENTS IN SANGER SEQUENCING TECHNOLOGY
  • Table 10: COMMERCIAL IN-VITRO AMPLIFICATION NGS TECHNOLOGIES
Sample Report

Recent Reports

Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO269A

The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.

Global DNA Forensics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO266A

The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

Global Blood Platelet Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO268A

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

Digital Biomarkers: Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO227B

The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.

Whole Genome Sequencing: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO271A

The global market for whole genome sequencing is expected to grow from $3 billion in 2025 and forecast to reach $6.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2030.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - IAS006Q

The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Water and Wastewater Treatment Technologies: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - ENV008G

The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.

Global Edge AI Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - IFT310A

The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Published - May-2005| Analyst - Ralph Hensler| Code - BIO045A

Report Highlights

  • Projected sales for the worldwide DNA sequencing and proteomics markets are expected to rise at an AAGR (average annual growth rate) of 17.6% from $7.8 billion in 2004 to $17.5 billion in 2009.
  • Drug discovery and healthcare currently are two of the largest market sectors, representing respectively, some 46% and 20% of revenues in 2004.
  • The food and renewable resource sector will grow at a modest pace motivated by the production of genetically altered food products offering better nutritional benefits and lower product costs.
  • The environment market sector has only begun to tap into the technology benefits and this basic research sector will grow given the possibility of new research fields that may emerge.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
DNA Sequencing: Emerging Technologies and Applications
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI: Your Say